Cargando…
Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Pediatric Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702119/ https://www.ncbi.nlm.nih.gov/pubmed/31319648 http://dx.doi.org/10.3345/kjp.2019.00472 |
| _version_ | 1783445158939852800 |
|---|---|
| author | Jang, Gwang Cheon |
| author_facet | Jang, Gwang Cheon |
| author_sort | Jang, Gwang Cheon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6702119 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Korean Pediatric Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67021192019-09-03 Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? Jang, Gwang Cheon Korean J Pediatr Editorial Korean Pediatric Society 2019-08 2019-06-24 /pmc/articles/PMC6702119/ /pubmed/31319648 http://dx.doi.org/10.3345/kjp.2019.00472 Text en Copyright © 2019 by The Korean Pediatric Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Jang, Gwang Cheon Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title_full | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title_fullStr | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title_full_unstemmed | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title_short | Why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| title_sort | why should we monitor for hematologic adverse drug reactions to oxcarbazepine? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702119/ https://www.ncbi.nlm.nih.gov/pubmed/31319648 http://dx.doi.org/10.3345/kjp.2019.00472 |
| work_keys_str_mv | AT janggwangcheon whyshouldwemonitorforhematologicadversedrugreactionstooxcarbazepine |